Top News

• Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options

  Tuesday, March 2, 2021 · Paul Archie

• Big Pharma Dives Into CBD: Who Could Be Next?

  Monday, February 22, 2021 · Paul Archie

• Clinical Trials Focus on COVID-19 and Acute Myocarditis

  Tuesday, January 19, 2021 · Paul Archie

• Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™

  Tuesday, December 22, 2020 · Paul Archie

• Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19

  Tuesday, December 15, 2020 · Paul Archie